BRCA1：一种新的非小细胞肺癌放化疗疗效的预测基因

Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors worldwide. Chemotherapy and radiotherapy are the main methods in therapy of NSCLC. The identification and characterization of predictive markers of radio- and chemo-sensitivity will be beneficial with customized treatment...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2012
Materias:
综述
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999957/
https://www.ncbi.nlm.nih.gov/pubmed/22901997
http://dx.doi.org/10.3779/j.issn.1009-3419.2012.08.06
Descripción
Sumario:Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors worldwide. Chemotherapy and radiotherapy are the main methods in therapy of NSCLC. The identification and characterization of predictive markers of radio- and chemo-sensitivity will be beneficial with customized treatment of NSCLC patients. This article will review the evidence regarding breast cancer susceptibility gene 1 (BRCA1) as a new predictive marker for chemotherapy and radiotherapy of NSCLC.

Ejemplares similares